Linus Health Acquires Aural Analytics

Linus Health, a digital health company enabling early detection of Alzheimer's and other dementias, has acquired Aural Analytics, a clinical-grade speech analytics provider. Financial terms of the deal were not disclosed.

With the acquisition of Aural Analytics, Linus Health has added clinical-grade speech analytics to its platform to help researchers and clinicians identify cognitive impairment and better understand the characteristics of those impairments.

"Our voices reveal essential aspects of our mental state and brain function. Technology can extract such metrics with exquisite precision. Aural Analytics has worked in the development and processing of voice metrics, and integrating them with other signals captured by the Linus Health platform will substantially expand our unique brain health assessment capabilities," said Dr. Alvaro Pascual-Leone, Linus Health's chief medical officer and co-founder, in a statement.

Aural Analytics' speech analytics software, called Speech Vitals, is used by leading healthcare systems and life science organizations in pharmaceutical research and clinical trials. It collects samples of speech from patients via app-based tests and evaluates them to assess cognitive conditions. Speech Vitals' patented technology has been used to detect multiple neurological conditions, such as dementia, autism and ALS.

Aural Analytics and Linus Health have participated jointly in clinical trials, including Bio-Hermes. The experience revealed the promise of combining their respective offerings into a multimodal solution. Speech analysis yields insights into brain function.

Aural Analytics not only does speech analytics, but has proprietary technology in the acoustic analysis of voice. Integration of Aural's analyses into Linus Health's multimodal process-based assessments yields even deeper insights into brain function and the ability to identify early brain-related dysfunction quickly.